Highlights

  • Tilray shares fell 10% on Monday as anticipated cannabis rescheduling did not occur.
  • Investor optimism last week surged due to reports of a potential executive order.
  • Market uncertainty persists as U.S. marijuana laws remain a complex patchwork across states.

Tilray Brands (NASDAQ:TLRY) experienced a 10% decline in Monday trading following heightened investor expectations over marijuana rescheduling. Late last week, several media reports suggested that President Donald Trump might sign an executive order (EO) directing the Justice Department to begin reclassifying the drug.

Rescheduling Reports Drive Investor Activity
The Drug Enforcement Administration (DEA) currently classifies marijuana as a Schedule I substance, considered to have high risk and minimal medical value. Rescheduling would move marijuana to Schedule III, a category including medications like Tylenol, defined by the DEA as having moderate to low potential for dependence.

Friday’s surge in Tilray and other pot stocks was fueled by assumptions that the EO signing was imminent. However, Monday’s trading revealed a sharp pullback as the anticipated action did not take place, leaving investors to reassess positions.

Ongoing Market Uncertainty
The U.S. cannabis sector continues to face a fragmented legal landscape. Some states allow both recreational and medical use, some permit only medical use, and others restrict both. The current federal classification limits marijuana companies from accessing basic financial services, a challenge that rescheduling could address.

Until formal federal action occurs, trading based on potential legalization remains speculative. The stock’s recent volatility underscores the market’s sensitivity to news and regulatory developments surrounding cannabis in the U.S.

Share Price Snapshot
TLRY saw its shares close at USD 10.93 on December 15, marking a decline of 10.04% from the previous trading session. The stock opened at USD 12.39, reached a high of USD 12.59, and a low of USD 10.77 during the day.